Nefopam (HCl)
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Nefopam (HCl) is analgesic agent for the treatment of moderate to moderately severe pain. Nefopam (HCl) is chemically and pharmacologically distinct from any other class of analgesic. Chemically Nefopam (HCl) is identified as 3, 4, 5, 6-tetrahydro-5-methyl-1-phenyl-1H-2.5-benzoxazocine hydrochloride. Nefopam (HCl) is prepared by chemical synthesis and has a unique heterocyclic structure. Nefopam (HCl) is administered orally and parenterally.
Indications
Nefopam (HCl) is primarily indicated in conditions like Before surgery in women who have anemia due to uterine fibroids, Pain, and can also be given in adjunctive therapy as an alternative drug of choice in Cancer, Surgery.
Contraindications
Nefopam (HCl) is contraindicated in conditions like Epilepsy, Glaucoma, Myocardial infarction, Urinary retention (adynamic bladder),Prostatic hypertrophy, Convulsions.
Side Effects
The severe or irreversible adverse effects of Nefopam (HCl), which give rise to further complications include Convulsions, Hallucinations. The signs and symptoms that are produced after the acute overdosage of Nefopam (HCl) include Tachycardia, Convulsions, Hematuria, Hallucinations, Agitation, Coagulopathy, Patch necrosis of GI mucosa, Cerebral edema. The symptomatic adverse reactions produced by Nefopam (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Anorexia, Anxiety, Dry mouth, Dysphonia, Sleep disturbance, Sweating, Syncope, Euphoria.
Warnings
Nefopam should be used with caution in patients with glaucoma, urinary retention, impaired kidney or liver function or in elderly patients.
High Risk Groups
Drug should not be given to Pediatrics, Pregnant Mothers, Geriatrics, and Neonates. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
30 to 120 mg (75 (75)) 8 hourly PO —
Child Dosage
( ) — Not recommended in this age group
Neonatal Dosage
( ) — Not recommended in this age group
Drug Interactions
Nefopam (HCl) is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAspirinADVICE: Avoid concomitant use of Aspirin with NSAIDs (increased risk of side effects). CodeineDiazepamHalothaneHydroxyzineIndomethacinPentazocinePropiverine HydrochlorideTaking two or more antimuscarinic drugs together can increase their side effects.PropoxypheneRauwolfia ReserpineVORICONAZOLEVoriconazole may increase the serum concentration of nefazodone by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Storage
Inj Store at room temperature, Below 30°C. Do not Freeze. Tab Store Below 30°C.
Available Brands in Pakistan
2 active brands listed alphabetically.
INZA
ActiveMEDICEENA PHARMA (PVT) LTD.
DML: INZA
Tabs
NOVOPAM
ActiveHARMANN PHARMACEUTICAL LABORATORIES (PVT) LTD.
DML: NOVOPAM
Tabs
1 additional record is present but flagged "Unverified / Legacy" and not listed.
